JP2023504646A5 - - Google Patents
Info
- Publication number
- JP2023504646A5 JP2023504646A5 JP2022532833A JP2022532833A JP2023504646A5 JP 2023504646 A5 JP2023504646 A5 JP 2023504646A5 JP 2022532833 A JP2022532833 A JP 2022532833A JP 2022532833 A JP2022532833 A JP 2022532833A JP 2023504646 A5 JP2023504646 A5 JP 2023504646A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201911049985 | 2019-12-04 | ||
| IN201911049985 | 2019-12-04 | ||
| PCT/EP2020/084571 WO2021110887A1 (en) | 2019-12-04 | 2020-12-04 | Benzothiazepine compounds and their use as bile acid modulators |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023504646A JP2023504646A (ja) | 2023-02-06 |
| JP2023504646A5 true JP2023504646A5 (https=) | 2023-12-05 |
| JPWO2021110887A5 JPWO2021110887A5 (https=) | 2023-12-05 |
| JP7665621B2 JP7665621B2 (ja) | 2025-04-21 |
Family
ID=82196618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532833A Active JP7665621B2 (ja) | 2019-12-04 | 2020-12-04 | ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4069362A1 (https=) |
| JP (1) | JP7665621B2 (https=) |
| CN (1) | CN114786773B (https=) |
| CA (1) | CA3158175A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4188541B1 (en) * | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9800428D0 (en) * | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
| EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) * | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| JP6097695B2 (ja) * | 2010-11-08 | 2017-03-15 | アルビレオ アクチエボラグ | Ｉｂａｔ阻害剤および胆汁酸結合剤を含む薬学的組み合わせ |
-
2020
- 2020-12-04 CA CA3158175A patent/CA3158175A1/en active Pending
- 2020-12-04 EP EP20821144.1A patent/EP4069362A1/en active Pending
- 2020-12-04 JP JP2022532833A patent/JP7665621B2/ja active Active
- 2020-12-04 CN CN202080083824.3A patent/CN114786773B/zh active Active